Skip to main content

Product

OpenClaw

Latest development
Sep 25, 2026
Published intelligence
4
Active developments
0
Follow OpenClaw to track meaningful changes across developments involving OpenClaw.

Latest intelligence

Related developments

DevelopmentSources: 5 independent sources + 1 further report

Microsoft updates Copilot to unify business AI capabilities

CNBC reports that Microsoft is updating its Copilot application to combine multiple business AI capabilities into a unified app. The consolidation comes as Microsoft refines its commercial AI strategy to compete directly against rivals including Anthropic. Claims are as reported; this summary makes no determination about accuracy or significance.

  • Very high confidence
  • Strongly corroborated

Coverage

DevelopmentSources: 2 independent sources

Meta AI agent Muse reaches 500,000 users in first week

Meta's AI agent Muse gained over 500,000 users in its first week and reached the top ranking in Apple's App Store. Meta has acknowledged the application was heavily inspired by the open-source project OpenClaw amid findings of nearly identical file names and contents, while OpenAI is reportedly considering a competitive response. Claims are as reported; this summary makes no determination about accuracy or significance.

  • High confidence
  • Corroborated

Coverage

DevelopmentSources: Primary source + 7 independent reports

Meta launches personal assistant AI agent Muse

The Verge reports that Meta is launching Muse, a personal assistant AI agent aimed at broad consumer adoption. Claims are as reported; this summary makes no determination about accuracy or significance.

  • Very high confidence
  • Widely corroborated

Coverage

DevelopmentSources: 1 independent source

Networking vulnerability identified in OpenClaw enabling LLM poisoning via Ollama API

A newly identified networking vulnerability in Nvidia-associated tooling allows threat actors to gain unauthenticated access to local model servers through the Ollama API. Claims are as reported; this summary makes no determination about accuracy or significance.

  • Moderate confidence
  • Limited corroboration

Coverage